Latest Insider Transactions at Globe Life Inc. (GL)
This section provides a real-time view of insider transactions for Globe Life Inc. (GL). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of GLOBE LIFE INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of GLOBE LIFE INC.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 04
2025
|
Robert Edward Hensley EVP & Chief Investment Officer |
SELL
Open market or private sale
|
Direct |
1,610
-13.64%
|
$199,640
$124.81 P/Share
|
Mar 03
2025
|
Philip M Jacobs Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,183
+50.0%
|
-
|
Mar 03
2025
|
Matthew J Adams Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,183
+50.0%
|
-
|
Feb 28
2025
|
Michael Shane Henrie SVP & Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,220
+28.64%
|
-
|
Feb 28
2025
|
Rebecca E Zorn EVP & Chief Talent Officer |
BUY
Grant, award, or other acquisition
|
Direct |
980
+6.7%
|
-
|
Feb 28
2025
|
Dolores L Skarjune EVP and Chief Admin. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,205
+12.82%
|
-
|
Feb 28
2025
|
Christopher Kyle Tyler EVP and Chief Info Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,125
+17.66%
|
-
|
Feb 28
2025
|
Frank M Svoboda Co-Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,686
+11.0%
|
-
|
Feb 28
2025
|
Robert Brian Mitchell EVP, General Counsel and CRO |
BUY
Grant, award, or other acquisition
|
Direct |
1,310
+13.96%
|
-
|
Feb 28
2025
|
Michael Clay Majors EVP - Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,385
+2.86%
|
-
|
Feb 28
2025
|
Jennifer Allison Haworth EVP & Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,055
+5.69%
|
-
|
Feb 28
2025
|
Robert Edward Hensley EVP & Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,290
+9.85%
|
-
|
Feb 28
2025
|
James Matthew Darden Co-Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
3,686
+6.89%
|
-
|
Feb 26
2025
|
Rebecca E Zorn EVP & Chief Talent Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,746
-12.11%
|
$211,266
$121.93 P/Share
|
Feb 26
2025
|
Rebecca E Zorn EVP & Chief Talent Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,307
+23.01%
|
-
|
Feb 26
2025
|
Frank M Svoboda Co-Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,662
-15.14%
|
$564,102
$121.93 P/Share
|
Feb 26
2025
|
Frank M Svoboda Co-Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,845
+27.78%
|
-
|
Feb 26
2025
|
Robert Brian Mitchell EVP, General Counsel and CRO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,755
-28.94%
|
$333,355
$121.93 P/Share
|
Feb 26
2025
|
Robert Brian Mitchell EVP, General Counsel and CRO |
BUY
Grant, award, or other acquisition
|
Direct |
6,999
+42.37%
|
-
|
Feb 26
2025
|
Michael Clay Majors EVP - Chief Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,007
-6.18%
|
$363,847
$121.93 P/Share
|
Feb 26
2025
|
Michael Clay Majors EVP - Chief Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,537
+13.41%
|
-
|
Feb 26
2025
|
Jennifer Allison Haworth EVP & Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,907
-10.4%
|
$230,747
$121.93 P/Share
|
Feb 26
2025
|
Jennifer Allison Haworth EVP & Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,846
+20.91%
|
-
|
Feb 26
2025
|
Robert Edward Hensley EVP & Chief Investment Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,161
-17.05%
|
$261,481
$121.93 P/Share
|
Feb 26
2025
|
Robert Edward Hensley EVP & Chief Investment Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,384
+29.82%
|
-
|
Feb 26
2025
|
James Matthew Darden Co-Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,662
-9.17%
|
$564,102
$121.93 P/Share
|
Feb 26
2025
|
James Matthew Darden Co-Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,845
+18.9%
|
-
|
Feb 26
2025
|
Thomas Peter Kalmbach EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,004
-11.63%
|
$363,484
$121.93 P/Share
|
Feb 26
2025
|
Thomas Peter Kalmbach EVP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
7,537
+22.6%
|
-
|
Feb 14
2025
|
Frank M Svoboda Co-Chairman & CEO |
SELL
Open market or private sale
|
Direct |
10,750
-19.68%
|
$1,311,500
$122.76 P/Share
|
Feb 14
2025
|
Frank M Svoboda Co-Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,750
+26.58%
|
$935,250
$87.6 P/Share
|
Feb 13
2025
|
Frank M Svoboda Co-Chairman & CEO |
SELL
Open market or private sale
|
Direct |
11,000
-36.73%
|
$1,342,000
$122.31 P/Share
|
Feb 13
2025
|
Frank M Svoboda Co-Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+26.86%
|
$957,000
$87.6 P/Share
|
Feb 11
2025
|
James Matthew Darden Co-Chairman & CEO |
SELL
Open market or private sale
|
Direct |
24,890
-21.77%
|
$3,011,690
$121.63 P/Share
|
Feb 11
2025
|
James Matthew Darden Co-Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,890
+28.04%
|
$2,165,430
$87.6 P/Share
|
Feb 11
2025
|
Frank M Svoboda Co-Chairman & CEO |
SELL
Open market or private sale
|
Direct |
11,000
-19.99%
|
$1,331,000
$121.67 P/Share
|
Feb 11
2025
|
Frank M Svoboda Co-Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
11,000
+26.86%
|
$957,000
$87.6 P/Share
|
Feb 07
2025
|
Michael Shane Henrie SVP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
10,650
-47.09%
|
$1,299,300
$122.54 P/Share
|
Feb 07
2025
|
Michael Shane Henrie SVP & Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
10,650
+37.15%
|
$1,065,000
$100.78 P/Share
|
Feb 07
2025
|
Robert Brian Mitchell EVP, General Counsel and CRO |
SELL
Open market or private sale
|
Direct |
30,000
-59.56%
|
$3,630,000
$121.8 P/Share
|
Feb 07
2025
|
Robert Brian Mitchell EVP, General Counsel and CRO |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+47.98%
|
$2,460,000
$82.56 P/Share
|
Jan 06
2025
|
Frank M Svoboda Co-Chairman & CEO |
SELL
Open market or private sale
|
Direct |
13,448
-23.4%
|
$1,506,176
$112.7 P/Share
|
Jan 06
2025
|
Frank M Svoboda Co-Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
16,000
+33.06%
|
$1,392,000
$87.6 P/Share
|
Jan 06
2025
|
Michael Shane Henrie SVP & Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,500
-45.18%
|
$168,000
$112.32 P/Share
|
Jan 06
2025
|
Michael Shane Henrie SVP & Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+31.12%
|
$147,000
$98.32 P/Share
|
Jan 06
2025
|
Mark A Blinn Director |
SELL
Open market or private sale
|
Direct |
3,000
-36.94%
|
$339,000
$113.23 P/Share
|
Jan 06
2025
|
Jennifer Allison Haworth EVP & Chief Marketing Officer |
SELL
Open market or private sale
|
Direct |
9,000
-22.53%
|
$1,008,000
$112.92 P/Share
|
Jan 06
2025
|
Jennifer Allison Haworth EVP & Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+28.59%
|
$477,000
$53.61 P/Share
|
Jan 02
2025
|
Mary E Thigpen Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,604
+8.5%
|
-
|
Jan 02
2025
|
Cheryl Alston Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,604
+14.56%
|
-
|